Skip to main content

New trial seeks to improve survival rates for patients with COVID-19

A new trial is taking place at Addenbrooke’s Hospital to test whether COVID-19 patients with weak immune systems have a better chance of survival if they are injected with plasma from people who have successfully recovered from the virus.


The trial will examine whether antibody rich plasma, known as ‘convalescent plasma’ can be given to people who are struggling to develop an immune response to the illness. Scientists want to discover whether this treatment would improve a COVID-19 patient’s speed of recovery and chances of survival.

The clinical trial is being run nationally by NHS Blood and Transplant (NHSBT). Although there is some evidence of patient benefit, it will seek to confirm the safety and effectiveness of convalescent plasma transfusions. If successful, the plasma has the added benefit of being freezable, so donations can be stockpiled ahead of a potential second wave.

For more information visit: CUH News

Published June 8, 2020

Latest from CCTU

New clues about irritable bowel syndrome found in the brain

Breakthrough research led by Addenbrooke's Hospital gives IBS patients like Laura Tebbs a better understanding of their condition.

Researchers eye up new gene therapy trial that could reverse hereditary blindness

Restoration of sight from a rare genetic mutation may now become a reality thanks to a prestigious award from the National Institute for Health Research (…

Artificial pancreas trialled for outpatients with type 2 diabetes for first time

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis.

All news